Literature DB >> 24417601

Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.

Scott N Compton1, Tara S Peris2, Daniel Almirall3, Boris Birmaher4, Joel Sherrill5, Phillip C Kendall6, John S March1, Elizabeth A Gosch7, Golda S Ginsburg8, Moira A Rynn9, John C Piacentini10, James T McCracken10, Courtney P Keeton8, Cynthia M Suveg11, Sasha G Aschenbrand9, Dara Sakolsky4, Satish Iyengar4, John T Walkup12, Anne Marie Albano9.   

Abstract

OBJECTIVE: We sought to examine predictors and moderators of treatment outcomes among 488 youths ages 7-17 years (50% female; 74% ≤ 12 years) meeting Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; American Psychiatric Association, 2000) criteria for diagnoses of separation anxiety disorder, social phobia, or generalized anxiety disorder who were randomly assigned to receive either cognitive behavioral therapy (CBT), sertraline (SRT), their combination (COMB), or medication management with pill placebo (PBO) in the Child/Adolescent Anxiety Multimodal Study (CAMS).
METHOD: Six classes of predictor and moderator variables (22 variables) were identified from the literature and examined using continuous (Pediatric Anxiety Ratings Scale; PARS) and categorical (Clinical Global Impression Scale-Improvement; CGI-I) outcome measures.
RESULTS: Three baseline variables predicted better outcomes (independent of treatment condition) on the PARS, including low anxiety severity (as measured by parents and independent evaluators) and caregiver strain. No baseline variables were found to predict Week 12 responder status (CGI-I). Participants' principal diagnosis moderated treatment outcomes but only on the PARS. No baseline variables were found to moderate treatment outcomes on Week 12 responder status (CGI-I). DISCUSSION: Overall, anxious children responded favorably to CAMS treatments. However, having more severe and impairing anxiety, greater caregiver strain, and a principal diagnosis of social phobia were associated with less favorable outcomes. Clinical implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24417601      PMCID: PMC4056442          DOI: 10.1037/a0035458

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  65 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

Review 2.  Stratified randomization for clinical trials.

Authors:  W N Kernan; C M Viscoli; R W Makuch; L M Brass; R I Horwitz
Journal:  J Clin Epidemiol       Date:  1999-01       Impact factor: 6.437

3.  Further measures of the psychometric properties of the Children's Global Assessment Scale.

Authors:  H R Bird; G Canino; M Rubio-Stipec; J C Ribera
Journal:  Arch Gen Psychiatry       Date:  1987-09

4.  Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: long-term follow-up and predictors of outcome.

Authors:  Paula Barrett; Lara Farrell; Mark Dadds; Natalie Boulter
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-10       Impact factor: 8.829

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Clinical characteristics of anxiety disordered youth.

Authors:  Philip C Kendall; Scott N Compton; John T Walkup; Boris Birmaher; Anne Marie Albano; Joel Sherrill; Golda Ginsburg; Moira Rynn; James McCracken; Elizabeth Gosch; Courtney Keeton; Lindsey Bergman; Dara Sakolsky; Cindy Suveg; Satish Iyengar; John March; John Piacentini
Journal:  J Anxiety Disord       Date:  2010-02-06

7.  Psychometric properties of the state-trait inventory for cognitive and somatic anxiety (STICSA) in friendship dyads.

Authors:  Daniel F Gros; Leonard J Simms; Martin M Antony
Journal:  Behav Ther       Date:  2010-01-28

Review 8.  Predictors of treatment response in pediatric obsessive-compulsive disorder.

Authors:  Golda S Ginsburg; Julie Newman Kingery; Kelly L Drake; Marco A Grados
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-08       Impact factor: 8.829

9.  The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties.

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-09       Impact factor: 8.829

10.  Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

Authors:  Scott N Compton; John T Walkup; Anne Marie Albano; John C Piacentini; Boris Birmaher; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James T McCracken; Bruce D Waslick; Satish Iyengar; Phillip C Kendall; John S March
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2010-01-05       Impact factor: 3.033

View more
  67 in total

Review 1.  The use of medication in selective mutism: a systematic review.

Authors:  Katharina Manassis; Beate Oerbeck; Kristin Romvig Overgaard
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-11-09       Impact factor: 4.785

2.  Complementary Features of Attention Bias Modification Therapy and Cognitive-Behavioral Therapy in Pediatric Anxiety Disorders.

Authors:  Lauren K White; Stefanie Sequeira; Jennifer C Britton; Melissa A Brotman; Andrea L Gold; Erin Berman; Kenneth Towbin; Rany Abend; Nathan A Fox; Yair Bar-Haim; Ellen Leibenluft; Daniel S Pine
Journal:  Am J Psychiatry       Date:  2017-04-14       Impact factor: 18.112

3.  Personalizing and Delivering Treatment for Prolonged Grief in Youths.

Authors:  Philip C Kendall; Lesley A Norris; Margaret E Crane
Journal:  Am J Psychiatry       Date:  2021-04-01       Impact factor: 18.112

Review 4.  Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.

Authors:  Jeffrey R Strawn; Eric T Dobson; Lisa L Giles
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2016-12-30

5.  Maternal Acceptance Moderates Fear Ratings and Avoidance Behavior in Children.

Authors:  Yaara Shimshoni; Wendy K Silverman; Simon P Byrne; Eli R Lebowitz
Journal:  Child Psychiatry Hum Dev       Date:  2018-06

Review 6.  Parental involvement: contribution to childhood anxiety and its treatment.

Authors:  Chiaying Wei; Philip C Kendall
Journal:  Clin Child Fam Psychol Rev       Date:  2014-12

7.  Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study.

Authors:  Jerome H Taylor; Eli R Lebowitz; Ewgeni Jakubovski; Catherine G Coughlin; Wendy K Silverman; Michael H Bloch
Journal:  J Clin Child Adolesc Psychol       Date:  2017-09-28

Review 8.  Assessment and treatment of anxiety disorders in children and adolescents.

Authors:  Anna M Wehry; Katja Beesdo-Baum; Meghann M Hennelly; Sucheta D Connolly; Jeffrey R Strawn
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

9.  Child and Adolescent Adherence With Cognitive Behavioral Therapy for Anxiety: Predictors and Associations With Outcomes.

Authors:  Phyllis Lee; Asima Zehgeer; Golda S Ginsburg; James McCracken; Courtney Keeton; Philip C Kendall; Boris Birmaher; Dara Sakolsky; John Walkup; Tara Peris; Anne Marie Albano; Scott Compton
Journal:  J Clin Child Adolesc Psychol       Date:  2017-04-27

Review 10.  Long-Term Outcomes of Youth Treated for an Anxiety Disorder: A Critical Review.

Authors:  Brittany A Gibby; Elizabeth P Casline; Golda S Ginsburg
Journal:  Clin Child Fam Psychol Rev       Date:  2017-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.